On Jan. 18, 2019, Masonic Cancer Center researcher Branden Moriarity, PhD, received a U24 Grant with Recombinetics. The grant, part of the National Institutes of Health’s Common Fund’s Somatic Cell Gene Editing (SCGE) consortium, was awarded to continue work on testing gene-editing technologies.

The period of the grant is four years with $4 million dollars in funding. The SCGE program was developed by the NIH to create further progress in somatic genome editing.